Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CMOD- Block1 > Pharm: Drug Targets of Inflammation > Flashcards

Pharm: Drug Targets of Inflammation Flashcards

1
Q

Describe the MOA of the following anti-inflammatory drug(s):

Corticosteroids

A

Transcriptional regulation inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the MOA of the following anti-inflammatory drug(s):
NSAIDS
Zileuton

A

Synthesis inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the MOA of the following anti-inflammatory drug(s):
Certolizumab
Adalimumab

A

Soluble cytokine receptor

Blocking monoclonal antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the MOA of the following anti-inflammatory drug(s):
Antihistamines
Montelukast

A

Receptor blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Asthma is characterized by two distinct phases:

A

Bronchospastic phase: histamines (bronchospasm)

Inflammatory phase: PGs, LTs, PAF, MBP, eosinophil cationic protein (ECP), proteases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why are antihistamines not appropriate for treatment of asthma?

A

Antihistamines block the effects of histamine binding to H1 receptors, but currently no antihistamine has utility in preventing degranulation of mast cells. There are many other inflammatory products in mast cell granules that cause asthma symptoms in addition to histamine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

GATA-3, a transcription factor that is specifically expressed in T helper 2 (Th2) cells, is essential for the gene expression of these 3 cytokines that mediate allergic inflammation.

A

IL-4, IL-5, and IL-13

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

GATA-3 is activated by ACPs via the TCR ______ and co-stimulatory receptor _____ after which is is phosphorylated by p38 MAP kinase and translocates to the nucleus via the nuclear import protein _________ .

A

CD3; CD28; importin-alpha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Corticosteroids bound to glucocorticoid receptors inhibit GATA-3 function by:

A

Competing for nuclear entry via importin-alpha and also by inhibiting p38 MAP kinase through the induction of MAP kinase phosphatase-1. Corticosteroids act as indirect inhibitors of GATA-3.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Briefly describe the two major signalling pathways that lead to upregulation of transcriptional activity and how they work.

A

Nf-kB pathway:
Nf-kB (p50/p65 heterodimer) is bound to inhibitor called IkB. Binding of IL-1 or TNF to TLR on surface of cell causes IkB to be phosphorylated, releasing Nf-kB which travels to nucleus and initiates transcription of Nf-kB responsive genes.
Jak/STAT pathway:
IFN-gamma binds surface receptor of alpha subunit of heterodimer Jak. Jak subunits (alpha/beta) join and Jak1/Jak2 (non-receptor protein tyrosine kinases) are activated and phosphorylate critical tyrosine residues, signalling to STAT to come on over and get in on some of that phosphorylating action. STAT molecules dimerize and translocate to the nucleus and stimulate transcription of IFN-gamma regulated genes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

At present, bortezomib is the only drug that targets Nf-kB levels by inhibiting its activation through stabilization of the inhibitor protein _____ .

A

IkB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The Nf-kB pathway plays a central role in both inflammation and ________ .

A

Cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Is it advisable to use corticosteroids over an extended period of time?

A 
No. Can increase susceptibility to multi-system pathology to include:
Infection
Myopathy
Osteonecrosis/porosis
Neuro/psych symptoms
Metabolic disorders
Gastric ulcers
Hair in wrong places/thinning skin
Eye problems
Cardiovascular issues
vascular impermeability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Glucocorticoid (GCC) resistance is a problem. Name a few mechanisms by which cells can become resistant to GCCs?

A

Familial resistance
Receptor modification
Increased levels of pro-inflammatory TFs (AP1, JNK, STAT, JAK3)
Increased efflux of steroids from cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which NSAID irreversibly acetylates the catalytic site of COX?

A

Aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ibuprofen is a selective or non-selective COX inhibitor? (meaning it inhibits either COX 1 or COX 2)

A

Non-selective inhibitor, can inhibit production of PGs and Thromboxane

17
Q

Name a COX-2 specific inhibitor.

A

Celecoxib (Celebrex, Celebra)

18
Q

What are autacoids?

A

A family of cell signalling molecules that include prostaglandins (from COX) and leukotrienes (from LOX)

19
Q

Montelukast is a:

A

Leukotriene receptor antagonist

20
Q

Zileuton is a:

A

Leukotriene synthesis inhibitor

21
Q

Omalizumab is a drug reserved for hard-to-treat asthma cases that acts by binding and neutralizing _______ (Ig) before it binds to mast cells to inhibit histamine release.

A

IgE

22
Q

Interleukins have become a drug target to treat asthma. An example is ____, which induces steroid resistance and increases B cell secretion of IgE, IgE receptor expression on several inflammatory cells, increased mucus secretion and fibrosis and eotaxin (eosinophil chemotaxis) release from airway epithelium.

A

IL-13

23
Q

With regard to H1 receptor activation by histamine what is the clinical manifestation of activation of the following tissue:
Lungs

A

Asthma symptoms

24
Q

With regard to H1 receptor activation by histamine what is the clinical manifestation of activation of the following tissue:
Vascular smooth muscle

A

Erythema (redness of the skin or mucous membranes, caused by hyperemia of superficial capillaries)

25
Q

With regard to H1 receptor activation by histamine what is the clinical manifestation of activation of the following tissue:
Vascular endothelium

A 
Erythema
Wheal response (A wheal is a rounded or flat-topped, pale red papule or plaque that is characteristically evanescent, disappearing within 24 to 48 hours)
26
Q

With regard to H1 receptor activation by histamine what is the clinical manifestation of activation of the following tissue:
Peripheral nerves

A

Itchiness

Pain

27
Q

There are two generations of antihistamines. The first generation access the blood-brain barrier (BBB) and can produce ____________ effects in the CNS as an adverse effect.

A

anti-cholinergic effects

28
Q

There are two generations of antihistamines. The second generation drugs were designed to lack the ability to pass the ______, hence they are considered non-sedating in normal clinical use and they lack the CNS adverse effects.

A

BBB (blood-brain barrier)

29
Q

List 4 1st generation antihistamines

A

Promethazine
Dimenhyrinate
Chlorpheniramine
Diphenhydramine

30
Q

List 3 2nd generation antihistamines

A

Cetirizine
Fexofenadine
Loratadine

31
Q

Roflumilast is a new treatment for COPD. It selectively inhibits the action of ____________, which blocks the hydrolases and inactivation of cAMP, resulting in intracellular accumulation of cAMP, an action thought to decrease inflammatory activity, somehow.

A

phosphodiesterase-4 (PDE4)

32
Q

By Roflumilast inhibition of PDE4, the recruitment and activation of key inflammatory cells, including these 5 key playas, as well as the hyperplasia and hypertrophy of structural cells, including airway smooth-muscle cells, epithelial cells and sensory and cholinergic nerves.

A 
Mast cells
macrophages
T-lymphocytes
neutrophils
eosinophils
33
Q

Name the two cellular sources of TNF-alpha.

A

New production of soluble TNF-alpha and membrane-bound expression of TNF from which soluble TNF is cleaved.

34
Q

Is TNF-alpha capable of initiating either apoptosis or cell proliferation? What is this based upon?

A

Yes. The net effect of TNF depends on the relative proportion of type I and type II receptors, and can be activating or pro-apoptotic. No, he didn’t say what the difference is between Type I and Type II receptors.

35
Q

List 4 drugs that inhibit the activity of TNF-alpha.

A

Etanercept
Infliximab
Adalimumab
Certolizumab pegol

36
Q

Which of the 4 TNF-alpha inhibitors we discussed are capable of fixing complement? How are they able to do this?

A

Infliximab
Adalimumab
They are mAbs that contain an Fc region and are thus capable of fixing complement and inducing antibody dependent cytotoxicity.

37
Q

Which TNF-a inhibitor has the broadest disease spectrum of use? Name a few of the conditions they treat.

A

Adalimumab followed closely by Infliximab and Etanercept.

Diseases they treat: Ankylosing spondylitis, Crohn’s disease, other arthritic conditions, ulcerative colitis, psoriasis.

38
Q

T/F: Current drugs for treatment of inflammatory conditions are often ineffective or they adversely affect the patient through indiscriminate inhibition of multiple cross-connected cytokine signaling systems.

A

True

CMOD- Block1 (36 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions